2010 Speakers

Kirsten Black
Dr Kirsten Black trained in obstetrics and gynaecology and after completing the fellowship of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists, undertook a PhD at the Univsersity of London. She is a senior lecturer in the Department of Obstetrics and Gynaecology at the University of Sydney and her areas of clinical practice include menopause, early pregnancy and contraception.

Julie Briody
Julie Briody is currently employed as a Senior Hospital Scientist in the Department of Nuclear Medicine at the Children’s Hospital at Westmead, Sydney, Australia. She has a Bachelor of Science and a Masters degree in Biomedical Engineering from the University of New South Wales.  Whilst studying, she commenced part-time work at the Children’s Hospital assisting with measuring bone density in normal children and clinical patients.  On completion of her studies, she commenced full-time work at the Children’s Hospital and has now almost 20 years of experience in paediatric bone densitometry. She also has considerable experience in a variety of bone density and body composition research projects and drug trials resulting in over 40 publications.
In 2005, Julie was invited to become a faculty member for the Australian and New Zealand Bone and Mineral Society Clinical Densitometry Courses and has since been actively involved with lectures, workshops and the preparation of course material

Rory Clifton-Bligh
Dr Roderick Clifton-Bligh is Senior Lecturer in Medicine at the University of Sydney, and Staff Specialist in Endocrinology at Royal North Shore Hospital, Sydney. He completed a PhD in the genetics of thyroid disorders with Professor Chatterjee at the University of Cambridge. He now supervises twin research groups, one of which focuses on the molecular basis of endocrine neoplasms, and the other on metabolic bone disease. 
The Cancer Genetics Unit currently studies the genetics of thyroid cancer, adrenal cancer, phaechromocytoma, and pituitary neoplasms. The Metabolic Bone Research Unit studies calcium-sensing receptor gene mutations, oncogenic osteomalacia (and FGF23 biology in general) and the role of 1-alpha hydroxylase in osteoporosis

Michael Hooper
Michael Hooper has had a career long interest in Metabolic Bone Disease and in particular Osteoporosis and Paget’s Disease. 
He is a Clinical Associate Professor in the Department of Medicine at the University of Sydney attached to the Central Clinical School. Currently he has accreditation to the Sydney Adventist Hospital and to Norfolk Island Hospital. His Private rooms are at Gordon and RPAH Medical Centre.
Until January 2010 he was Area Head of the Bone and Mineral Stream in Endocrinology in the Sydney South West Area Health Service and Director of Diagnostic Endocrinology at RPAH with accreditation to Royal Prince Alfred Hospital and Concord Hospital and as a Consultant in bone and mineral disorders to The New Children’s Hospital at Westmead,
He was Founding Honorary Secretary and a past President of the Australian and New Zealand Bone and Mineral Society and continues to be involved in Society affairs including his role as a permanent faculty member of the Densitometry Training Courses.
He is active in the Royal Australasian College of Physicians where he is Honorary Treasurer, Member of the Board, past President of the Adult Medicine Division, past chair the Adult Medicine POC for the RACP ASM and on several committees including the NSW State Committee

Mary McQuade
Ms Mary McQuade has worked in Endocrinology   in since 1985 at the Children’s Hospital at Westmead (formally the Royal Alexandria Hospital for Children). During this time Mary has held  several positions including Diabetes Educator , Nurse Unit Manager of the Endocrine ward and Endocrine testing  unit. In 2002 she became the Bisphosphonate Treatment Program (BTP) co ordinator  when there were approximately 100 patients on the program.This program now has  over 300 patients receiving  referrals from various specialities such as Orthopaedics . Genetics, Rehabilitation, Oncology, Rheumatology, Haemotology, Gastroenterology, Immuninology and Neurology. 
Mary’s role also involves liaising with medical, nursing and allied health staff about the patients and the programand acting . Ms McQuade acts as a ‘resource’ person for GP’s, paediatricians, community services, metropolitianmetropolitan and rural hospitals, and other paediatric hospitals throughout Australia.The focus of Mary’s position involves meeting   patients and their families to discuss therapy, complications and expected outcomes. 
Mary is also responsible for educating and supervising nursing staff when patients are receivinge bisphosphonates treatment on the wards at the Children’s Hospital Westmead plus following these patients and monitors management   post infusion.Ms McQuade arranges several clinics for patient reviews and follow up with the Endocrinologist.Mary considers herself very fortunate to be in the a position,  working in this ground breaking area of the the treatment of such diverse bone diseases, withand their management with   bisphosphonate therapy

Dr Craig Munns MBBS, PhD, FRACP
Dr Munns is a Senior Staff Specialist in Bone and Mineral Medicine and Endocrinology at the Children’s Hospital at Westmead, Sydney, Australia. Following the completion of his Paediatric and Endocrinology training at The Royal Children’s Hospital, Brisbane, Australia, Dr Munns spent two years as a Clinical Associate in Genetic and Metabolic Bone Disorders at the Shriners Hospital for Children, Montreal, Canada.  
Dr Munns was awarded his PhD through the University of Queensland in 2004. He is expert in the diagnosis and management of primary and secondary paediatric bone disorders. This remains his primary research interest and he has published numerous papers in this field.

Markus J Seibel, MD PhD FRACP FGABJS
Professor and Chair of Endocrino¬logy, The University of Sydney Head, Department of Endocrinology & Metabolism, Concord Hospital, Sydney. Director, Bone Research Program, ANZAC Research Institute, Sydney, Australia 
Markus Seibel completed his medical training in Germany (Universities of Mainz and Heidelberg), Switzerland (University of Basel), and in the US (Columbia University, New York).From 1991 – 2001, he was a staff member at the Department of Endocrinology and Metabolism, University of Heidelberg, Germany, where he served as the Deputy Director from 1999. In late 2001, Markus was appointed Chair and Professor or Endocrinology at the University of Sydney, Sydney, Australia. He currently heads the Department of Endocrinology & Meta¬bolism at Concord Hospital, Sydney, and the Bone Research Program at the prestigious ANZAC Research Institute, located on the same Campus.
Markus was the Past-President of the German Academy of Bone and Joint Sciences, is an active member of numerous professional societies and on the Editorial Boards of various endocrine and bone journals, including the JBMR. He is a Council Member of the Australian New Zealand Bone and Mineral Society (ANZBMS).  
The focus of his clinical and research activities is the pathophysio¬logy of bone metabolism, especially in osteoporosis and metastatic bone disease. He authored over 350 scientific articles, reviews, editorials and book chapters, and is the editor of six books

Sonia Stanton
Sonia Stanton graduated from the University of Sydney in 1993 (Medicine). She subsequently undertook physicians training in Sydney and Canberra teaching hospitals, completing her Endocrinology training in 1999. She worked in private practice in the ACT for 9 years before taking up a Staff Specialist Position in Endocrinology at The Canberra Hospital in 2009. In addition to working in the general endocrinology and diabetes clinics she runs a bone/calcium dysregulation clinic working in collaboration with the orthopaedic team and fracture clinic.

Duncan Topliss
Duncan Topliss is Director of the Department of Endocrinology and Diabetes at the Alfred Hospital, Melbourne, and Professor of Medicine in the Department of Medicine, Monash University. He is a past-President and Life Member of the Endocrine Society of Australia.He has been a frequent presenter at meetings of the Endocrine Society of Australia. He is a past winner and organizer of endocrine trivial pursuit contests for the ESA.He has a long-standing interest in the management of thyroid disease and thyroid cancer, and in the prevention and management of acute and chronic complications of diabetes. He has been an investigator on several major international diabetes trials. He has a wide interest in clinical endocrinology including osteoporosis, pituitary and adrenal disease, and endocrine hypertension. He is a member of the editorial board of Clinical Endocrinology and a frequent reviewer for Clinical Endocrinology, Thyroid, and other endocrine journals. 
His other interest is drug regulation and safety: he is a member of the Australian Advisory Committees on the Safety of Medicine (ACSOM) and Prescription Medicines (ACPM) of the TGA